Cargando…
Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?
Autores principales: | Stella, Giulia Maria, Bortolotto, Chandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688431/ https://www.ncbi.nlm.nih.gov/pubmed/36428633 http://dx.doi.org/10.3390/cancers14225540 |
Ejemplares similares
-
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Ricciardi, Sara, et al.
Publicado: (2021) -
Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
por: Cantini, Luca, et al.
Publicado: (2020) -
Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?
por: Gao, Yanyun, et al.
Publicado: (2022) -
The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma
por: Lettieri, Sara, et al.
Publicado: (2021) -
Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge
por: Abbott, David Michael, et al.
Publicado: (2020)